Search results for "Hemostatic"

showing 10 items of 48 documents

Reduced inotropic support after aprotinin therapy during pediatric cardiac operations

1999

Several reports indicate that aprotinin treatment before and during cardiopulmonary bypass (CPB) might have a protective effect on the myocardium. We evaluated the hemodynamic effects of perioperative aprotinin treatment.We conducted a randomized, double-blind, placebo-controlled trial in 34 infants (mean age, 2.5 years) who had cardiac operations. Half of the patients received high-dose aprotinin therapy. There were no significant differences between the aprotinin and placebo groups with respect to age, weight, sex, aortic cross-clamp time, and CPB time. The following data were recorded at arrival in the intensive care unit 6, 12, 24, and 48 hours after termination of CPB: heart rate, bloo…

Heart Defects CongenitalMalePulmonary and Respiratory MedicineAdolescentPhosphodiesterase InhibitorsHemodynamicsPlaceboHemostaticslaw.inventionAprotininDouble-Blind MethodlawHeart rateCardiopulmonary bypassHumansMedicineEnoximoneAprotininChildEnoximoneCardiopulmonary Bypassbusiness.industryHemodynamicsInfant NewbornInfantFurosemideBlood pressureChild PreschoolAnesthesiaFemaleSurgeryCardiology and Cardiovascular Medicinebusinesshormones hormone substitutes and hormone antagonistsmedicine.drugThe Annals of Thoracic Surgery
researchProduct

Effect of hemostatic agent on marginal gaps of class V giomer restorations

2017

Background Contamination of dentin with hemostatic agents might exert a deleterious effect on adhesive procedures on dentin. The present study was undertaken to investigate the effect of aluminum chloride hemostatic agent on marginal gaps in Cl V giomer restorations. Material and Methods Fifty sound bovine permanent incisors were selected for the purpose of this in vitro study and Cl V cavities were prepared on their buccal surfaces; the gingival margins of the cavities were placed in dentin. The tooth samples were randomly assigned to two groups (n=25). The samples in groups 1 and 2 underwent a restorative procedure without and with the application of aluminum chloride hemostatic agent in …

Hemostatic AgentChemistrybusiness.industryResearchDentistryDental Adhesives:CIENCIAS MÉDICAS [UNESCO]Operative Dentistry and EndodonticsBeautibondmedicine.anatomical_structureRestorative materialUNESCO::CIENCIAS MÉDICASDentinmedicineIn vitro studybusinessGeneral DentistryGingival margin
researchProduct

Letter to the Editor Regarding “Gelatin Paste as an Alternative Cost-Effective Hemostatic Agent in Cranial Surgery: Doing More with Less”

2019

Hemostatic Agentmedicine.medical_specialtyGelatin spongefood.ingredientLetter to the editorSettore MED/27 - Neurochirurgiabusiness.industryCranial surgeryGelatin Sponge AbsorbableGelatinHemostaticsHemostaticsSurgeryfoodGelatinMedicineSurgeryNeurology (clinical)businessWorld Neurosurgery
researchProduct

Hemostatic agents used in apical surgery: a review

2011

Objective: A review was made of the current literature on hemostatic agents used in apical surgery in order to determine their effectiveness and adverse effects. Material and methods: The main search terms used were: endodontic surgery, apicoectomy, apical surgery, periradicular surgery, hemostasis, hemostatic agents, and bleeding control. The authors searched the Medline database for articles published up to 1 September 2010. Experimental and clinical studies comparing the effectiveness and/ or adverse effects of two or more hemostatic agents and published between 2000 and 2010 were included in the review. Results: Four studies were analyzed: two clinical studies and two experimental studi…

Hemostatic Agentmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentOdontología:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryClinical trialBlood pressureApical surgeryHemostasisApicoectomyUNESCO::CIENCIAS MÉDICASmedicineAdverse effectbusinessMedline databaseGeneral Dentistry
researchProduct

Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis

2003

Abstract Background & aims: Emergency sclerotherapy is used as a first-line therapy for variceal bleeding in cirrhosis, although pharmacologic treatment stops bleeding in most patients. We performed a meta-analysis comparing emergency sclerotherapy with pharmacologic treatment. Methods: MEDLINE (1968–2002), EMBASE (1986–2002), and the Cochrane Library (2002;4) were searched to retrieve randomized controlled trials comparing sclerotherapy with vasopressin (± nitroglycerin), terlipressin, somatostatin, or octreotide for variceal bleeding in cirrhosis. Outcome measures were failure to control bleeding, rebleeding, blood transfusions, adverse events, and mortality. Results: Fifteen trials were …

Liver CirrhosisEmergency Medical ServicesVariceal bleedingmedicine.medical_specialtyCirrhosisVasopressinsmedicine.medical_treatmentOctreotideLypressinCochrane LibraryEsophageal and Gastric VaricesOctreotideGastroenterologyHemostaticslaw.inventionRandomized controlled triallawVasoactiveInternal medicineSclerotherapySclerotherapyHumansVasoconstrictor AgentsMedicineAdverse effectRandomized Controlled Trials as TopicHepatologybusiness.industryGastroenterologymedicine.diseaseHormonesSurgeryAnesthesiaMeta-analysisAcute DiseaseTerlipressinVaricesGastrointestinal HemorrhageSomatostatinbusinessTerlipressinmedicine.drugEuropean Journal of Gastroenterology & Hepatology
researchProduct

Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial.

1998

beta-Blockers and sclerotherapy prevent long-term upper digestive rebleeding in cirrhosis but they seem ineffective for early rebleeding. We compared octreotide with a placebo for the prevention of early rebleeding in cirrhotic patients. After control of acute upper digestive bleeding, 262 consecutive cirrhotic patients were randomized to octreotide 100 microgram subcutaneously three times a day for 15 days (n = 131) or to the placebo (n = 131), in a double blind pragmatic trial in which beta-blockers and/or sclerotherapy were allowed together with the experimental treatment. Separate randomization and analysis were performed according to whether patients were eligible for beta-blockers and…

Liver CirrhosisMalemedicine.medical_specialtyRandomizationmedicine.medical_treatmentAdrenergic beta-AntagonistsOctreotidePlaceboOctreotideHemostaticsPlacebosDouble-Blind MethodMelenaRecurrenceSclerotherapymedicineSclerotherapyHumansHepatologybusiness.industryHematemesisLength of StayMiddle AgedSurgeryClinical trialSurvival RateTreatment OutcomeChemoprophylaxisFemaleComplicationVaricesbusinessGastrointestinal Hemorrhagemedicine.drugHepatology (Baltimore, Md.)
researchProduct

Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients.

2010

Background Emergency sclerotherapy is still widely used as a first line therapy for variceal bleeding in patients with cirrhosis, particularly when banding ligation is not available or feasible. However, pharmacological treatment may stop bleeding in the majority of these patients. Objectives To assess the benefits and harms of emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis. Search methods Search of trials was based on The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, and Science Citation Index Expanded through January 2010. Selection criteri…

Liver Cirrhosismedicine.medical_specialtyCirrhosisVasopressinsmedicine.medical_treatmentOctreotideLypressinCochrane LibraryEsophageal and Gastric VaricesOctreotideGastroenterologyHemostaticsInternal medicineSclerotherapymedicineSclerotherapyHumansVasoconstrictor AgentsPharmacology (medical)Adverse effectbusiness.industrymedicine.diseaseHemostaticsClinical trialTreatment OutcomeAnesthesiaEmergenciesTerlipressinbusinessGastrointestinal HemorrhageSomatostatinTerlipressinmedicine.drugThe Cochrane database of systematic reviews
researchProduct

[Hemostatic effectiveness of TachoSil® patches in radiofrequency assisted minor hepatic resection].

2011

Aim. Intra- and postoperative bleeding represents an extremely serious and frequent complication of hepatic surgery. The aim of this study was to evaluate the effectiveness of TachoSil (R) to improve hemostasis in radiofrequency assisted minor hepatic resection. Methods. Between July 2008 and June 2010, 31 patients underwent radiofrequency assisted minor hepatic resection. At the end of the liver resection a sponge of TachoSil (R) was applied on the liver. Results. The mean intraoperative bleeding from the liver was 56.1 mL (range 0-300 mL). No patients received intra- and postoperative blood transfusion. Surgical drains were removed between the first and the sixth-eight postoperative day. …

Liver neoplasms surgery; Haemostasis; Liver diseasesAdultAged 80 and overMaleSurgical SpongesHemostatic TechniquesLiver DiseasesThrombinFibrinogenLiver neoplasms surgeryMiddle AgedCombined Modality TherapySettore MED/18 - Chirurgia GeneraleDrug CombinationsHaemostasiCatheter AblationHepatectomyHumansFemaleAgedMinerva chirurgica
researchProduct

Systemic hemostatic agents initiated in trauma patients in the pre-hospital setting: a systematic review

2022

Abstract Purpose The effect of systemic hemostatic agents initiated during pre-hospital care of severely injured patients with ongoing bleeding or traumatic brain injury (TBI) remains controversial. A systematic review and meta-analysis was therefore conducted to assess the effectiveness and safety of systemic hemostatic agents as an adjunctive therapy in people with major trauma and hemorrhage or TBI in the context of developing the Italian National Institute of Health guidelines on major trauma integrated management. Methods PubMed, Embase, and Cochrane Library databases were searched up to October 2021 for studies that investigated pre-hospital initiated treatment with systemic hemostati…

Major traumaSystematic reviewEmergency MedicineSystemic hemostatic agentsPre-hospitalOrthopedics and Sports MedicineSurgeryNursingCritical Care and Intensive Care MedicineSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSystemic hemostatic agentEuropean Journal of Trauma and Emergency Surgery
researchProduct

Hemostatic, inflammatory, and oxidative markers in pesticide user farmers

2016

Research Article; International audience; The aim of this work was to investigate inflammatory, oxidative, and thrombotic parameters as biomarkers in farmers exposed to pesticides. Fifty farmers using chemical pesticides and 60 unexposed control men participated in this study. The Mediterranean diet compliance, the duration of pesticide use, and personal protection for pesticides handling were recorded using self-administered questionnaires. Serum biochemical parameters, oxidant/antioxidant, inflammatory, and thrombosis markers were determined. Our findings showed oxidative stress reflected by an increase in malondialdehyde, carbonyl proteins and superoxide anion levels and a decrease in vi…

Male0301 basic medicineAntioxidantHealth Toxicology and Mutagenesismedicine.medical_treatment[ SDV.TOX ] Life Sciences [q-bio]/ToxicologyClinical BiochemistryPhysiologyAscorbic AcidMetribuzin010501 environmental sciencesmedicine.disease_cause01 natural sciencesBiochemistryHemostaticsProtein Carbonylationchemistry.chemical_compoundOrganophosphateSuperoxidesimmune system diseasesMalondialdehydeSurveys and QuestionnairesVitamin Eoxidative stressStresspersistent organic pollutantsLymphocytesFarmersbiologyPersistent organic pollutantsfood and beveragesMiddle AgedCatalaseMalondialdehydeGlutathioneC-Reactive ProteinCatalaseMalathionProthrombinOxidation-ReductionResearch ArticleAdultAgricultural HealthStressExposureSuperoxide dismutase03 medical and health sciencesOccupational ExposuremedicineHumansPesticidespesticidethrombosis0105 earth and related environmental sciencesSuperoxide Dismutasebusiness.industryVitamin EFibrinogen[ SDV.BIO ] Life Sciences [q-bio]/BiotechnologyPesticideAscorbic acidrespiratory tract diseasesBiotechnologyLogistic Models030104 developmental biologychemistryinflammationIn-VitroSusceptibilitybiology.proteinbusinessBiomarkersOxidative stressBiomarkers
researchProduct